Skip to content

Ayurvedic management of Headache

Evaluation of the comparative efficacy of Rasnadi Taila Nasya (Standard control) and Dashmoola Taila Nasya (Trial drug) in the management of Vataja Shirahshoola - an open label double arm randomized clinical trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/04/024487
Enrollment
60
Registered
2020-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: G894- Chronic pain syndrome Health Condition 3: G894- Chronic pain syndrome

Interventions

Intervention1: Rasnadi Taila Nasya: Nasya (nasal administration) of Rasnadi taila (in two sittings, each for seven days, with a gap of 7 days in between the two sittings of nasya) alongwith oral admin

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having the signs and symptoms of Vatika Shirahshoola as given in Ayurvedic classics will be selected. Patients should be willing to participate in the trial.

Exclusion criteria

Exclusion criteria: 1. Patients not having vatika shirahshoola. 2. Age less than 15 and greater than 50 years. 3. Pregnant and lactating women. 4.Patients suffering from major systemic diseases viz. T.B., cancer, diabetes mellitus, heart diseases, hypertension. 5. Headache due to refractive error and increased intra-ocular pressure. 6. Headache due to involvement of other doshas except vata. 7. Secondary headache due to other pathological conditions e.g. tumors, cerebral haemorrhagic conditions. 8. Traumatic injury. 9. Nasya ayogya patients as per classical texts will be excluded.

Design outcomes

Primary

MeasureTime frame
Relief in the signs and symptoms of Vataja ShirahshoolaTimepoint: 30 days for oral treatment, two sittings of nasya (7 days in each sitting)

Secondary

MeasureTime frame
Improvement in quality of lifeTimepoint: 30 days for oral treatment, two sittings of nasya (7 days in each sitting)

Countries

India

Contacts

Public ContactDr Pankaj Kundal

All India Institute of Ayurveda

drpankajkundal@yahoo.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026